ACN Newswire

Fri Jul 24

SinoMab entered into Strategic Collaboration with D2M

Written by ACN Newswire

HONG KONG, Jul 23, 2020 - (ACN Newswire) - SinoMab BioScience Limited ("SinoMab" of the "Company", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that SinoMab and D2M...

ACN Newswire

SinoMab entered into Strategic Collaboration with D2M

As coronavirus hits holiday lettings, a shift to longer rentals could help many of us

Australia's 2017 environment scorecard: like a broken record, high temperatures further stress our ecosystems

The case for a rent holiday for businesses on the coronavirus economic frontline

As weary Britons head to the polls again, parties seem incapable of handling the nation's problems

Government agrees to national anti-corruption body – with strict limits

Very risky business: the pros and cons of insurance companies embracing artificial intelligence

New Zealand outstrips Australia, UK and US with $12 billion coronavirus package for business and people in isolation

Driverless cars could create new jobs in a welcome boost to Australia's motor industry

View from The Hill: Palmer flypaper sticky for both sides

Slicing up Apple’s profits: despite record sales it’s not all sweetness

Coronavirus has boosted telehealth care in mental health, so let's keep it up